Table 1 Patient characteristics (n = 151)
Characteristics | N = 151 |
|---|---|
Gender (male/female) | 89/62 |
Median age (years, range) | 10 (1–17) |
FAB type | |
M0 | 5 |
M1 | 4 |
M2 | 43 |
M4 | 17 |
M5 | 57 |
M6 | 11 |
M7 | 10 |
MDS-AML | 3 |
Therapy-related AML | 1 |
Cytogenetics and molecular abnormalities | |
Intermediate | 94 |
Unfavorable | 57 |
Disease status before allo-HSCT | |
CR1 | 132 |
CR2 | 15 |
NR | 4 |
Donor type | |
ISD | 13 |
URD | 5 |
Haplo-RD | 129 |
UCB | 4 |
Median MNC (×10^8/kg, range) | 8.57 (0.59–16.66) |
Median CD34 (×10^6/kg, range) | 2.85 (0.17–10.95) |
NE engraftment (n, %) | 151 (100.0%) |
Median time from HSCT to NE engraftment (days, range) | 12 (10–23) |
PLT engraftment (n, %) | 146 (96.7%) |
Median time from HSCT to PLT engraftment (days, range) | 15.5 (7–128) |